Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ New drop for temporary presbyopia relief approved ➤ First-in-human results for accommodating IOL ➤ Enrollment complete in Phase 2/3 trial for Stargardt therapy ➤ Type C meeting completed with FDA to advance urcosimod for neuropathic corneal pain ➤ Company news ➤ ASCRS news and events
➤ FDA review extended for dry eye disease treatment ➤ Key data gathered for expected NDA submission ➤ Phase 2b results for GA treatment ➤ Phase 3 studies discontinued for thyroid eye disease ➤ ASCRS news and events
“To take something known and look at it from a new direction, to question our view of reality, to wonder, these are the strengths of children, but also of innovators,” said Julie Schallhorn, MD, introducing and commenting on the articles in the Cornea section of this issue.
Amniotic membrane products can be a valuable tool to aid in the treatment of a variety of corneal diseases and can be added to other treatments to help patients find relief. Two ophthalmologists discussed the different types of products available and best applications.
➤ FDA grants IDE for synthetic endothelial layer study ➤ NDA submission for wet AMD treatment advances ➤ Positive feedback moves forward NDA submission plans ➤ Company news ➤ ASCRS news and events
It was a successful year for the Journal of Cataract & Refractive Surgery (JCRS), the official journal of ASCRS and ESCRS, and JCRS Online Case Reports (JCRO), an online-only companion journal to JCRS. To celebrate this success, EyeWorld is featuring some of the most-viewed papers.
➤ FDA approves treatment for macular edema following RVO ➤ New cyclosporine product receives approval for dry eye ➤ First human implant of 3D-bioprinted cornea ➤ Topline results from Phase 3 trial for Stargardt disease ➤ First patient treated with IDE glaucoma therapy ➤ Enrollment complete for Phase 2 trial for geographic atrophy treatment ➤ First patient implanted with investigational glaucoma shunt in trial ➤ Positive review of Phase 3 pivotal trial for AMD ➤ Company news ➤ ASCRS news and events
Ophthalmologists, particularly corneal specialists, may encounter a variety of pathogens that can cause infectious keratitis. Two of these specialists went into detail on some of the infections, including those that may be considered “atypical,” and how to identify and diagnose them.
A pair of recent studies from the Diabetes Endothelial Keratoplasty Study Group published in JAMA Ophthalmology found that diabetes status did not affect success of DMEK outcomes overall, nor did it result in greater endothelial cell loss when compared to tissue from a donor without diabetes.
➤ Complete response letter issued for low-dose atropine drop ➤ Extension study shows reduced GA growth with intravitreal treatment ➤ Durable, 3-year vision improvements seen with optogenetic therapy ➤ Preclinical data supports long-acting nature of investigational anti-VEGF for wet AMD ➤ Company news ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.